4

FORM 4 SUBMISSION

Company: AMICUS THERAPEUTICS, INC.
Filed: May 16, 2018
Period of Report: May 16, 2018
Accession Number: 0001209191-18-030678

View Document ↗ View on SEC.gov ↗